Mecanismos de señalización celular en enfermedades hepáticas, cardiovasculares y cáncer
Goethe University Frankfurt
Francfort, AlemaniaPublicaciones en colaboración con investigadores/as de Goethe University Frankfurt (10)
2019
-
Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body
Cell, Vol. 179, Núm. 7, pp. 1661-1676.e19
2018
-
Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)” (Redox Biol. (2017) 13 (94–162)(S2213231717303373)(10.1016/j.redox.2017.05.007))
Redox Biology
-
PHD3 controls lung cancer metastasis and resistance to EGFR inhibitors through TGFa
Cancer Research, Vol. 78, Núm. 7, pp. 1805-1819
2017
-
BMP-9 interferes with liver regeneration and promotes liver fibrosis
Gut, Vol. 66, Núm. 5, pp. 939-954
-
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
Redox Biology, Vol. 13, pp. 94-162
2016
-
EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance
Nature Communications, Vol. 7
2014
-
Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR
Nature Communications, Vol. 5
2013
-
Basement Membrane-Rich Organoids with Functional Human Blood Vessels Are Permissive Niches for Human Breast Cancer Metastasis
PLoS ONE, Vol. 8, Núm. 8
-
Generation and characterization of monospecific and bispecific hexavalent trimerbodies
mAbs, Vol. 5, Núm. 1, pp. 70-79
-
Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies
Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 34, pp. 13791-13796